Medical Letter on the CDC and FDA

Cancer - Delcath Systems Granted Orphan-Drug Designations for Cutaneous and Ocular Melanoma

Cancer Vaccines - Mexican Department of Public Health to Launch Screening for Papillomavirus, Cause of Cervical Cancer

Caraco Pharmaceutical Laboratories, Ltd. - Caraco Pharmaceutical Laboratories, Ltd. Update on FDA Warning Letter

Chevron Energy Solutions - U.S. Army, Chevron and Keenan Development Receive 2008 National Council for Public-Private Partnerships' Infrastructure Award

Clinical Trial Research - Duska Therapeutics Applies for Phase 3 Special Protocol Assessment

Critical Path Institute - C-Path Expands Partnerships to Speed Development of Critical New Drug Therapies

Drug Development - U.S. Files Suit Against New Jersey Generic Drug Manufacturer That Distributed Adulterated and Misbranded Products

Drug Safety - United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit

Epilepsy - FDA Approves BANZEL(TM) (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder

Food and Drug Law Institute - FDLI Names 2009 Distinguished Service and Leadership Award Recipients

Food Poisoning - USFoodSafety.com, a One-Stop Source for the Latest Food Recalls, Alerts, Food Safety Articles and Professional Food Safety Practices, Launches Today

Gen-Probe - Promising Clinical Data on Gen-Probe's APTIMA HPV Test Presented at Major European Medical Meeting

GlaxoSmithKline - FDA Approves Promacta Eltrombopag, the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder

Hair Loss - How the Economy is Changing the Hair Loss Treatment Industry

HIV/AIDS - Long-Term TITAN Study Evaluates PREZISTA(R)/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults

Hypertension - FREEDOM-C Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Fails to Meet Primary Endpoint

Lower Back Pain - Neuromed Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED-1077

Marketing and Licensing Agreements - American HealthChoice Announces the First Sales of the OmniBody Scan

Non-Small Cell Lung Cancer - Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer

Osteoporosis - Hagens Berman Files Class Action Against Bayer Healthcare Over Misleading Marketing Campaign

Osteosarcoma - IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma in Eu

Ovarian Cancer - Ortho Biotech Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer

Parkinson Disease - Mayo Clinic Develops Potential New Therapy to Stop the Progression of Parkinson's Disease

Patents - Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation

Regulatory Actions - Arpida Announces Posting of Briefing Documents for FDA Anti-Infective Drugs Advisory Committee Meeting on iclaprim

Regulatory Actions - Innocoll Receives Fast Track Designation for Gentamicin Surgical Implant

Regulatory Actions - Mortara Instrument Announces Extension of ECG Warehouse CRADA With US FDA

Regulatory Actions - Mylan Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules

Regulatory Actions - Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase

Skin Cancer - Panel Demands FDA Action to Address Dramatic Increases in Skin Cancer in U.S.

Stanford University Medical Center - New imaging technique tracks cancer-killing cells over prolonged period

Vaccines - GeneThera Releases Results From Initial Animal Tests of E.Coli O157:h7 Vaccine Amid News of Increase of E.Coli Discoveries in Beef Products

Xytis, Inc. - Xytis to Initiate First-In-Class Phase I Clinical Trials with Alpha 7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator XY4083